Status lab-led Areas Pandemic Host Response and Disease, Innate Immune Signaling and the Interferon Response
If the defining feature of this infection is a muted interferon response, the obvious inference is to supply the missing arm, and several lines of evidence made that attractive. Testing it required the full course of infection across tissues in a host where an unmodified clinical isolate causes progressive lower respiratory disease. It also required deciding what antiviral transcription away from the airway means, since it could report local infection or a signal arriving from elsewhere, and those readings imply different interventions.
Hoagland 2021 built the platform and the intervention together in golden hamsters, which are permissive without host genetic modification. Because Ifnb1 was unannotated in that genome, the authors assembled, cloned and functionally validated a candidate transcript, which is what made interferon biology readable in the species. Ten plaque-forming units sufficed to seed the lower respiratory tract and raising the inoculum a thousandfold did not increase replication, inflammation moved from upper to lower airway over several days, and olfactory bulb, brain and small intestine showed strong antiviral transcription at viral reads orders of magnitude below respiratory levels. Intranasal universal interferon alpha A/D, given before challenge or one day after, lowered infectious virus and proinflammatory transcripts, shifted the infiltrate away from neutrophils and prevented transmission in three of five exposed animals, with a double-stranded RNA mimetic giving comparable activity. The paper attributed the distal antiviral state speculatively to disseminated viral RNA.
Carrau 2023 tested that attribution and reported for the alternative. Whole blood carried an interferon-stimulated gene signature with no interferon transcripts of its own, and a fibroblast bioassay detected roughly sixty units per millilitre of circulating interferon at one day. Three independent manipulations pointed the same way. Dexamethasone delayed airway induction without changing early lung titres and permitted infectious virus in liver, spleen, olfactory bulb and gastrointestinal tract with transient viremia. Intravenous inoculation bypassed the airway and produced productive infection of kidney, liver, spleen, heart and gastrointestinal tract. Prior airway infection before intravenous challenge reduced distal loads. Circulating interferon was detected only in animals with lung titres, whatever the route.
Two things are now known. Extrapulmonary interferon signalling is a protective output of the lung rather than evidence of distal infection, and how fast the airway engages determines where the virus can establish. This is also a recorded internal correction, since Hoagland 2021 proposed disseminated viral material and Carrau 2023 from the same laboratory found for circulating interferon. What is not established is any molecular mechanism. Circulating interferon was read by bioassay rather than measured directly, because hamster reagents were unavailable, and type I and type III were not separated. Dexamethasone is a broad suppressor and direct effects on distal organs cannot be excluded, the intravenous arm used a thousandfold higher dose so route and dose are not independent, and viremia was detectable only after amplification. Young animals that clear the virus represent neither age nor lethal disease, the intranasal interferon result carries no human dosing implication, and extension of the model to severe human COVID-19 or to Long Covid is offered by the authors as speculation.
Substantiated by - Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity, delivers the longitudinal multi-tissue atlas with an annotated Ifnb1 and shows local interferon lowering virus, pathology and transmission - Delayed engagement of host defenses enables SARS-CoV-2 viremia and productive infection of distal organs in the hamster model of COVID-19, shows by three independent manipulations that airway-derived circulating interferon primes distal organs and restricts tropism
In golden hamsters, productive SARS-CoV-2 replication in the airways generates circulating type I and III interferon that primes every organ against infection, and blunting or bypassing that airway response permits viremia and productive infection of liver, kidney, spleen and brain.
Longitudinal transcriptional and histological profiling of SARS-CoV-2 infected golden hamsters maps a wave of inflammation that reaches tissues with little or no productive replication, and shows that intranasal type I interferon given before or after challenge lowers viral load and disease burden.